News
Cambridge launches clinical trial to test new drug for a rare lung condition
People with pulmonary sarcoidosis are being invited to take part in an international clinical trial at Cambridge University Hospitals. Read more
Cambridge-led study discovers cause of pregnancy sickness – and potential treatment
A study supported by NIHR Cambridge BRC has shown why many women experience nausea and vomiting during pregnancy – and why some women become so sick they need to be admitted to hospital.Read more
Research nurse’s poster on complex cancer study wins first prize at public event
Jason Domingo, senior clinical research charge nurse from the NIHR Cambridge Clinical Research Facility has won the poster competition at the NIHR Cambridge BRC open eveningRead more
Newborn babies at risk from bacteria commonly carried by mothers
One in 200 newborns is admitted to a neonatal unit with sepsis caused by a bacteria commonly carried by their mothers – much greater than the previous estimate, say Cambridge researchers.Read more
Prestigious NIHR Research Professorship awarded to Cambridge researcher
Congratulations to co-theme lead for the NIHR Cambridge BRC Data Science and Population Health theme, Professor Angela Wood, who has been awarded an NIHR research professorship.Read more
Cambridge announced as a major collaborator in new paediatric HealthTech Research Centre
NIHR Cambridge BRC researchers will be supporting a new paediatric research centre hosted by Sheffield, which aims to develop new technologies that improve healthcare in children and young people. Read more
Lab-grown ‘small blood vessels’ point to potential treatment for major cause of stroke and vascular dementia
Cambridge scientists have grown small blood vessel-like models in the lab and used them to show how damage to the scaffolding that support these vessels can cause them to leak, leading to conditions such as vascular dementia and stroke.Read more
Commercial Research update
From Mid-October as part of work to improve the set-up of commercial studies in the UK, local contract negotiation is changing in Stage 2 of the National Contract Value Review (NCVR).Read more
World-first trial to provide hearing for children with rare type of genetic hearing loss launches in Cambridge
NIHR Cambridge BRC is supporting a world-first trial to see whether gene therapy can provide hearing for children with severe to profound hearing loss due to a rare genetic condition.Read more
Obesity accelerates loss of COVID-19 vaccination immunity, study finds
A new study has found the protection offered by COVID-19 vaccination declines more rapidly in people with severe obesity than in those with normal weight. It suggests that people with obesity are likely to need more frequent booster doses to maintain their immunity.Read more
New study recommends replacing skull section after brain bleed treatment
A new trial has found – where possible – surgeons should replace the removed section of the skull following surgery to treat a form of brain bleed. Researchers say the approach will save patients undergoing skull reconstruction further down the line.Read more
Volunteers needed for new needle-free coronavirus vaccine at CRF
Recruitment is underway in Cambridge for volunteers to take part in clinical trials of a revolutionary new needle-free vaccine to protect against COVID-19.Read more
Cambridge researcher wins prestigious award for rare eye disease gene replacement therapy research
Neuroscience researcher Professor Patrick Yu-Wai-Man has won the 2023 Ludwig von Sallmann Clinician-Scientist Award from the Association for Research in Vision and Ophthalmology (ARVO) Foundation.
The award was given in recognition of Prof Read more
Cambridge researchers honoured at Microbiology Society Annual Awards
Congratulations to Professors Sharon Peacock and Ravindra Gupta who received top awards at the Microbiology Society Annual Awards.
The Microbiology Society awards recognise excellence and are made to those making significant contributions in Read more
Underactive immune response may explain obesity link to COVID-19 severity
Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response.Read more
Major funding for Cambridge will help find new cancer treatments
Around £3 million has been awarded to clinicians and scientists in Cambridge to support cancer research and find new treatments. Read more
NICE recommends Cambridge-developed ‘artificial pancreas’ for use on NHS for management of type 1 diabetes
The artificial pancreas for type 1 diabetes – which was developed in Cambridge and supported in trials by the NIHR Cambridge BRC and NIHR Cambridge CRF – could soon be approved for use Read more
Gone fishing: highly accurate test for common respiratory viruses uses DNA as ‘bait’
Research supported by NIHR Cambridge BRC has led to a new test that ‘fishes’ for multiple respiratory viruses at once using single strands of DNA as ‘bait’, giving highly accurate results in under Read more
Artificial pancreas successfully trialled for use by type 2 diabetes patients
Cambridge researchers have successfully trialled an artificial pancreas for people living with type 2 diabetes. Read more
Professor Krishna Chatterjee awarded a CBE
Professor Krishna Chatterjee, director of NIHR Cambridge Clinical Research Facility, has been awarded a CBE in the King’s New Year Honours.Read more
Discover more about the NIHR Cambridge BRC
Contact us by phone, email or web for more information.
Events Calendar
Listing relevant events and training sessions for researchers and members of the public.